tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market
9IB
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports

Infant Bacterial Therapeutics AB (9IB) Cash flow

4 Followers

Infant Bacterial Therapeutics AB Cash Flow

DE:9IB's free cash flow for Q2 2025 was kr-15.91M. For the 2025 fiscal year, DE:9IB's free cash flow was decreased by kr-11.91M and operating cash flow was kr-15.91M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -113.13Mkr -101.22Mkr -85.80Mkr -55.62Mkr -58.39M
Investing Cash Flow
kr 0.00kr -4.15Mkr -1.00Kkr 0.00kr 0.00
Financing Cash Flow
kr 2.01Mkr 96.52Mkr 1.88Mkr 91.00Kkr 1.76M
End Cash Position
kr 223.39Mkr 329.06Mkr 335.84Mkr 386.75Mkr 423.44M
Free Cash Flow
kr -113.13Mkr -101.22Mkr -85.80Mkr -55.62Mkr -58.39M
Currency in SEK

Infant Bacterial Therapeutics AB Cash Flow